Treating Autism with tPBM: New EEG Evidence - K Sverdlov & E Steingold, JelikaLite @Synchrony2022

Transcranial photobiomodulation (TPBM) is emerging as a promising treatment modality for Autism Spectrum Disorder. JelikaLite is conducting an open label study with 20 participants, aged 2-7 years old. Each child receives tPBM, which is administered via the Cognilum device, developed by Jelikalite. Cognilum previously received from the FDA a of Breakthrough Device Designation. The device is stimulating targeted brain areas with pulsed near infra-red light. The treatment is administered over the course of 10 weeks, twice a week, for 6-12 minutes, following a short titration period. Each child received at least 16 sessions of full dosage of Cognilum treatment. In addition, we collected EEG data from each child over the course of the study.
The current results reveal: significant reduction of symptoms, as measured by the change in before and after Childhood Autism Rating Scores; Significant decrease in the Delta Waves over the course of treatment; Significant increase in the intensity of Gamma Waves over the course of the treatment.
The results indicate that tPBM (possibly due to its anti-inflammatory effect) could be an effective treatment modality for ASD. Future research is needed to specify the possible underlying neuroinflammatory process as well as optimal doses to personalize the treatment.
🎥 This talk was part of Synchrony 2022 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation
🎥 For more Synchrony 2022 talks and highlights: • Synchrony Symposium 20...
🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠
Synchrony synchronysympo... is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder.
🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠
The BRAIN Foundation brainfoundatio... is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care.
To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.